Biosyent Inc BIOYF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6.26
- Day Range
- $6.28–6.28
- 52-Week Range
- $5.26–6.97
- Bid/Ask
- $5.27 / $6.51
- Market Cap
- $72.91 Mil
- Volume/Avg
- 156 / 2,488
Key Statistics
- Price/Earnings (Normalized)
- 15.05
- Price/Sales
- 3.27
- Dividend Yield (Trailing)
- 1.95%
- Dividend Yield (Forward)
- 1.56%
- Total Yield
- 5.35%
Company Profile
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.biosyent.com
Comparables
Valuation
|
Metric
|
BIOYF
|
600713
|
SCLX
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.05 | 10.83 | — |
Price/Book Value | 2.81 | 0.98 | — |
Price/Sales | 3.27 | 0.11 | 2.65 |
Price/Cash Flow | 16.03 | — | — |
Price/Earnings
BIOYF
600713
SCLX
Financial Strength
|
Metric
|
BIOYF
|
600713
|
SCLX
|
|---|---|---|---|
Quick Ratio | 5.37 | — | 0.15 |
Current Ratio | 6.48 | — | 0.19 |
Interest Coverage | 109.21 | — | −106.04 |
Quick Ratio
BIOYF
600713
SCLX
Profitability
|
Metric
|
BIOYF
|
600713
|
SCLX
|
|---|---|---|---|
Return on Assets (Normalized) | 17.44% | — | −106.47% |
Return on Equity (Normalized) | 20.79% | — | — |
Return on Invested Capital (Normalized) | 17.86% | — | −1,960.39% |
Return on Assets
BIOYF
600713
SCLX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yycgktmfr | Xzvqrw | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Qlbxtjzlnl | Tfcr | $70.0 Bil | |
HLN
| Haleon PLC ADR | Nhvzbjff | Jqtb | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yllpxrjr | Hlnn | $14.5 Bil | |
VTRS
| Viatris Inc | Bsvzngvj | Rjg | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kbsbldcx | Lhj | $11.9 Bil | |
CTLT
| Catalent Inc | Xqzssnjt | Gskkj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dbwrxvwg | Xbrt | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Vslfyblmw | Sds | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rhkrjdmd | Fzplynw | $3.5 Bil |